Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2021 | Ablaze Pharmaceuticals | $75.0M Series A | Vivo Capital, Advantech Capital | Novo Ventures, venBio, Nan Fung Life Sciences, Pivotal bioVenture Partners China, Samsara BioCapital, Venrock |